Ovixan (Mometasone Furoate)

Mometasone furoate, the active ingredient in Ovixan, is a glucocorticoid presented as a topical formulation for dermatological use. It treats inflammatory skin conditions such as eczema, psoriasis and dermatitis in adult and pediatric patients. GNH USA supplies Ovixan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ovixan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ovixan, a potent glucocorticoid, is employed in the management of inflammatory skin disorders.

- Atopic dermatitis: Reduces redness, itching and swelling. - Psoriasis plaque: Decreases plaque thickness and scaling. - Contact dermatitis: Alleviates irritation and erythema. - Seborrheic dermatitis: Controls flaking and inflammation. - Lichen planus: Mitigates lesions and associated discomfort.

Mometasone furoate may cause a range of skin‑related adverse reactions.

Common Side Effects: - Burning sensation - Itching - Dry skin - Redness - Folliculitis - Skin atrophy

Serious or Rare Side Effects: - Secondary infection - Hypersensitivity reaction - Severe skin thinning - Telangiectasia - Systemic cortisol suppression

When using Ovix-​​  

- Apply   t    t  ewline -   ewline -   ewline   ewline   ewline -  ewline -  ewline - Store   ewline

The   t  

   t  ewline  ewline

t \n t  ewline 

t  t \n ewline ullet ullet ullet ullet ullet